Literature DB >> 28538170

YAP Regulates Actin Dynamics through ARHGAP29 and Promotes Metastasis.

Yiting Qiao1, Jianxiang Chen2, Ying Bena Lim3, Megan Louise Finch-Edmondson4, Veerabrahma Pratap Seshachalam5, Lei Qin4, Tingting Jiang6, Boon Chuan Low7, Himanshu Singh3, Chwee Teck Lim8, Marius Sudol9.   

Abstract

Yes-associated protein (YAP) is regulated by mechanical cues via the interaction of the Hippo pathway with cytoskeleton. Previous studies showed that YAP plays a role in regulating the actomyosin network by suppressing Rho GTPase in medaka fish. Here, we identify Rho GTPase activating protein 29 (ARHGAP29) as a transcriptional target of YAP in a human gastric cancer cell line. YAP promotes the expression of ARHGAP29 to suppress the RhoA-LIMK-cofilin pathway, destabilizing F-actin. The overexpression of YAP causes cytoskeletal rearrangement by altering the dynamics of F-actin/G-actin turnover, thus promoting migration. In a mouse model, circulating tumor cells (CTCs) exhibit an increased ARHGAP29 RNA level compared with cells at primary tumor sites, and the metastatic potential of CTCs is positively correlated with ARHGAP29 expression. Moreover, increased ARHGAP29 expression is correlated with shortened survival of human gastric cancer patients. Our study provides a model to understand YAP's contribution to cancer metastasis via regulation of actin dynamics.
Copyright © 2017 National University of Singapore. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ARHGAP29; RhoA; YAP; actin; atomic force microscopy; gastric cancer; metastasis

Mesh:

Substances:

Year:  2017        PMID: 28538170     DOI: 10.1016/j.celrep.2017.04.075

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  77 in total

1.  TGFβ and Hippo Pathways Cooperate to Enhance Sarcomagenesis and Metastasis through the Hyaluronan-Mediated Motility Receptor (HMMR).

Authors:  Shuai Ye; Ying Liu; Ashley M Fuller; Rohan Katti; Gabrielle E Ciotti; Susan Chor; Md Zahidul Alam; Samir Devalaraja; Kristin Lorent; Kristy Weber; Malay Haldar; Michael A Pack; T S Karin Eisinger-Mathason
Journal:  Mol Cancer Res       Date:  2020-01-27       Impact factor: 5.852

Review 2.  An overview of signaling pathways regulating YAP/TAZ activity.

Authors:  Boon Chin Heng; Xuehui Zhang; Dominique Aubel; Yunyang Bai; Xiaochan Li; Yan Wei; Martin Fussenegger; Xuliang Deng
Journal:  Cell Mol Life Sci       Date:  2020-08-03       Impact factor: 9.261

3.  ARHGAP29 Mutation Is Associated with Abnormal Oral Epithelial Adhesions.

Authors:  B J Paul; K Palmer; J C Sharp; C H Pratt; S A Murray; M Dunnwald
Journal:  J Dent Res       Date:  2017-08-17       Impact factor: 6.116

4.  Mechanistic insights into anticancer properties of oligomeric proanthocyanidins from grape seeds in colorectal cancer.

Authors:  Preethi Ravindranathan; Divya Pasham; Uthra Balaji; Jacob Cardenas; Jinghua Gu; Shusuke Toden; Ajay Goel
Journal:  Carcinogenesis       Date:  2018-05-28       Impact factor: 4.944

5.  PRDM4 mediates YAP-induced cell invasion by activating leukocyte-specific integrin β2 expression.

Authors:  Huan Liu; Xiaoming Dai; Xiaolei Cao; Huan Yan; Xinyan Ji; Haitao Zhang; Shuying Shen; Yuan Si; Hailong Zhang; Jianfeng Chen; Li Li; Jonathan C Zhao; Jindan Yu; Xin-Hua Feng; Bin Zhao
Journal:  EMBO Rep       Date:  2018-04-17       Impact factor: 8.807

Review 6.  Convergence of VEGF and YAP/TAZ signaling: Implications for angiogenesis and cancer biology.

Authors:  Ameer L Elaimy; Arthur M Mercurio
Journal:  Sci Signal       Date:  2018-10-16       Impact factor: 8.192

7.  YAP-TEAD signaling promotes basal cell carcinoma development via a c-JUN/AP1 axis.

Authors:  Dejan Maglic; Karin Schlegelmilch; Antonella Fm Dost; Riccardo Panero; Michael T Dill; Raffaele A Calogero; Fernando D Camargo
Journal:  EMBO J       Date:  2018-07-23       Impact factor: 11.598

8.  PRICKLE1 promotes gastric cancer metastasis by activating mTOR signaling.

Authors:  Rongjian Zhou; Zhaoqing Tang; Haojie Li; Xuefei Wang; Yihong Sun
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 9.  The HIPPO pathway in gynecological malignancies.

Authors:  Dongying Wang; Jiaxing He; Junxue Dong; Thomas F Meyer; Tianmin Xu
Journal:  Am J Cancer Res       Date:  2020-02-01       Impact factor: 6.166

10.  Elucidation of WW domain ligand binding specificities in the Hippo pathway reveals STXBP4 as YAP inhibitor.

Authors:  Rebecca E Vargas; Vy Thuy Duong; Han Han; Albert Paul Ta; Yuxuan Chen; Shiji Zhao; Bing Yang; Gayoung Seo; Kimberly Chuc; Sunwoo Oh; Amal El Ali; Olga V Razorenova; Junjie Chen; Ray Luo; Xu Li; Wenqi Wang
Journal:  EMBO J       Date:  2019-11-29       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.